Intramuscular Vaccine Adjuvants is used for Intramuscular injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.
The global market for Intramuscular Vaccine Adjuvants is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Intramuscular Vaccine Adjuvants market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Intramuscular Vaccine Adjuvants market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Intramuscular Vaccine Adjuvants market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Intramuscular Vaccine Adjuvants market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Intramuscular Vaccine Adjuvants players cover GSK, Dynavax Technologies, Novavax, Agenus and Croda International, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Intramuscular Vaccine Adjuvants market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Intramuscular Vaccine Adjuvants market, with both quantitative and qualitative data, to help readers understand how the Intramuscular Vaccine Adjuvants market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Intramuscular Vaccine Adjuvants market and forecasts the market size by Type (Infectious Diseases, Cancer and Others), by Application (Research Applications and Commercial Applications.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Infectious Diseases
Cancer
Others
Segmentation by application
Research Applications
Commercial Applications
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
GSK
Dynavax Technologies
Novavax
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
Chapter Introduction
Chapter 1: Scope of Intramuscular Vaccine Adjuvants, Research Methodology, etc.
Chapter 2: Executive Summary, global Intramuscular Vaccine Adjuvants market size (sales and revenue) and CAGR, Intramuscular Vaccine Adjuvants market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Intramuscular Vaccine Adjuvants sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Intramuscular Vaccine Adjuvants sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Intramuscular Vaccine Adjuvants market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including GSK, Dynavax Technologies, Novavax, Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health and Associated British Foods, etc.
Chapter 14: Research Findings and Conclusion
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intramuscular Vaccine Adjuvants Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intramuscular Vaccine Adjuvants by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intramuscular Vaccine Adjuvants by Country/Region, 2017, 2022 & 2028
2.2 Intramuscular Vaccine Adjuvants Segment by Type
2.2.1 Infectious Diseases
2.2.2 Cancer
2.2.3 Others
2.3 Intramuscular Vaccine Adjuvants Sales by Type
2.3.1 Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2017-2022)
2.3.2 Global Intramuscular Vaccine Adjuvants Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intramuscular Vaccine Adjuvants Sale Price by Type (2017-2022)
2.4 Intramuscular Vaccine Adjuvants Segment by Application
2.4.1 Research Applications
2.4.2 Commercial Applications
2.5 Intramuscular Vaccine Adjuvants Sales by Application
2.5.1 Global Intramuscular Vaccine Adjuvants Sale Market Share by Application (2017-2022)
2.5.2 Global Intramuscular Vaccine Adjuvants Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intramuscular Vaccine Adjuvants Sale Price by Application (2017-2022)
3 Global Intramuscular Vaccine Adjuvants by Company
3.1 Global Intramuscular Vaccine Adjuvants Breakdown Data by Company
3.1.1 Global Intramuscular Vaccine Adjuvants Annual Sales by Company (2020-2022)
3.1.2 Global Intramuscular Vaccine Adjuvants Sales Market Share by Company (2020-2022)
3.2 Global Intramuscular Vaccine Adjuvants Annual Revenue by Company (2020-2022)
3.2.1 Global Intramuscular Vaccine Adjuvants Revenue by Company (2020-2022)
3.2.2 Global Intramuscular Vaccine Adjuvants Revenue Market Share by Company (2020-2022)
3.3 Global Intramuscular Vaccine Adjuvants Sale Price by Company
3.4 Key Manufacturers Intramuscular Vaccine Adjuvants Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intramuscular Vaccine Adjuvants Product Location Distribution
3.4.2 Players Intramuscular Vaccine Adjuvants Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Intramuscular Vaccine Adjuvants by Geographic Region
4.1 World Historic Intramuscular Vaccine Adjuvants Market Size by Geographic Region (2017-2022)
4.1.1 Global Intramuscular Vaccine Adjuvants Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intramuscular Vaccine Adjuvants Annual Revenue by Geographic Region
4.2 World Historic Intramuscular Vaccine Adjuvants Market Size by Country/Region (2017-2022)
4.2.1 Global Intramuscular Vaccine Adjuvants Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intramuscular Vaccine Adjuvants Annual Revenue by Country/Region
4.3 Americas Intramuscular Vaccine Adjuvants Sales Growth
4.4 APAC Intramuscular Vaccine Adjuvants Sales Growth
4.5 Europe Intramuscular Vaccine Adjuvants Sales Growth
4.6 Middle East & Africa Intramuscular Vaccine Adjuvants Sales Growth
5 Americas
5.1 Americas Intramuscular Vaccine Adjuvants Sales by Country
5.1.1 Americas Intramuscular Vaccine Adjuvants Sales by Country (2017-2022)
5.1.2 Americas Intramuscular Vaccine Adjuvants Revenue by Country (2017-2022)
5.2 Americas Intramuscular Vaccine Adjuvants Sales by Type
5.3 Americas Intramuscular Vaccine Adjuvants Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intramuscular Vaccine Adjuvants Sales by Region
6.1.1 APAC Intramuscular Vaccine Adjuvants Sales by Region (2017-2022)
6.1.2 APAC Intramuscular Vaccine Adjuvants Revenue by Region (2017-2022)
6.2 APAC Intramuscular Vaccine Adjuvants Sales by Type
6.3 APAC Intramuscular Vaccine Adjuvants Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intramuscular Vaccine Adjuvants by Country
7.1.1 Europe Intramuscular Vaccine Adjuvants Sales by Country (2017-2022)
7.1.2 Europe Intramuscular Vaccine Adjuvants Revenue by Country (2017-2022)
7.2 Europe Intramuscular Vaccine Adjuvants Sales by Type
7.3 Europe Intramuscular Vaccine Adjuvants Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intramuscular Vaccine Adjuvants by Country
8.1.1 Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intramuscular Vaccine Adjuvants Revenue by Country (2017-2022)
8.2 Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Type
8.3 Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intramuscular Vaccine Adjuvants
10.3 Manufacturing Process Analysis of Intramuscular Vaccine Adjuvants
10.4 Industry Chain Structure of Intramuscular Vaccine Adjuvants
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intramuscular Vaccine Adjuvants Distributors
11.3 Intramuscular Vaccine Adjuvants Customer
12 World Forecast Review for Intramuscular Vaccine Adjuvants by Geographic Region
12.1 Global Intramuscular Vaccine Adjuvants Market Size Forecast by Region
12.1.1 Global Intramuscular Vaccine Adjuvants Forecast by Region (2023-2028)
12.1.2 Global Intramuscular Vaccine Adjuvants Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intramuscular Vaccine Adjuvants Forecast by Type
12.7 Global Intramuscular Vaccine Adjuvants Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Intramuscular Vaccine Adjuvants Product Offered
13.1.3 GSK Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Dynavax Technologies
13.2.1 Dynavax Technologies Company Information
13.2.2 Dynavax Technologies Intramuscular Vaccine Adjuvants Product Offered
13.2.3 Dynavax Technologies Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Dynavax Technologies Main Business Overview
13.2.5 Dynavax Technologies Latest Developments
13.3 Novavax
13.3.1 Novavax Company Information
13.3.2 Novavax Intramuscular Vaccine Adjuvants Product Offered
13.3.3 Novavax Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novavax Main Business Overview
13.3.5 Novavax Latest Developments
13.4 Agenus
13.4.1 Agenus Company Information
13.4.2 Agenus Intramuscular Vaccine Adjuvants Product Offered
13.4.3 Agenus Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Agenus Main Business Overview
13.4.5 Agenus Latest Developments
13.5 Croda International
13.5.1 Croda International Company Information
13.5.2 Croda International Intramuscular Vaccine Adjuvants Product Offered
13.5.3 Croda International Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Croda International Main Business Overview
13.5.5 Croda International Latest Developments
13.6 Seppic
13.6.1 Seppic Company Information
13.6.2 Seppic Intramuscular Vaccine Adjuvants Product Offered
13.6.3 Seppic Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Seppic Main Business Overview
13.6.5 Seppic Latest Developments
13.7 OZ Biosciences
13.7.1 OZ Biosciences Company Information
13.7.2 OZ Biosciences Intramuscular Vaccine Adjuvants Product Offered
13.7.3 OZ Biosciences Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 OZ Biosciences Main Business Overview
13.7.5 OZ Biosciences Latest Developments
13.8 Phibro Animal Health
13.8.1 Phibro Animal Health Company Information
13.8.2 Phibro Animal Health Intramuscular Vaccine Adjuvants Product Offered
13.8.3 Phibro Animal Health Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Phibro Animal Health Main Business Overview
13.8.5 Phibro Animal Health Latest Developments
13.9 Associated British Foods
13.9.1 Associated British Foods Company Information
13.9.2 Associated British Foods Intramuscular Vaccine Adjuvants Product Offered
13.9.3 Associated British Foods Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Associated British Foods Main Business Overview
13.9.5 Associated British Foods Latest Developments
13.10 InvivoGen
13.10.1 InvivoGen Company Information
13.10.2 InvivoGen Intramuscular Vaccine Adjuvants Product Offered
13.10.3 InvivoGen Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 InvivoGen Main Business Overview
13.10.5 InvivoGen Latest Developments
13.11 Merck KGaA
13.11.1 Merck KGaA Company Information
13.11.2 Merck KGaA Intramuscular Vaccine Adjuvants Product Offered
13.11.3 Merck KGaA Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Merck KGaA Main Business Overview
13.11.5 Merck KGaA Latest Developments
13.12 CSL Limited
13.12.1 CSL Limited Company Information
13.12.2 CSL Limited Intramuscular Vaccine Adjuvants Product Offered
13.12.3 CSL Limited Intramuscular Vaccine Adjuvants Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CSL Limited Main Business Overview
13.12.5 CSL Limited Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Intramuscular Vaccine Adjuvants Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intramuscular Vaccine Adjuvants Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Infectious Diseases
Table 4. Major Players of Cancer
Table 5. Major Players of Others
Table 6. Global Intramuscular Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 7. Global Intramuscular Vaccine Adjuvants Sales Market Share by Type (2017-2022)
Table 8. Global Intramuscular Vaccine Adjuvants Revenue by Type (2017-2022) & ($ million)
Table 9. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2017-2022)
Table 10. Global Intramuscular Vaccine Adjuvants Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Intramuscular Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 12. Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2017-2022)
Table 13. Global Intramuscular Vaccine Adjuvants Revenue by Application (2017-2022)
Table 14. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application (2017-2022)
Table 15. Global Intramuscular Vaccine Adjuvants Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Intramuscular Vaccine Adjuvants Sales by Company (2020-2022) & (K Units)
Table 17. Global Intramuscular Vaccine Adjuvants Sales Market Share by Company (2020-2022)
Table 18. Global Intramuscular Vaccine Adjuvants Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Company (2020-2022)
Table 20. Global Intramuscular Vaccine Adjuvants Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Intramuscular Vaccine Adjuvants Producing Area Distribution and Sales Area
Table 22. Players Intramuscular Vaccine Adjuvants Products Offered
Table 23. Intramuscular Vaccine Adjuvants Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Intramuscular Vaccine Adjuvants Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Intramuscular Vaccine Adjuvants Sales Market Share Geographic Region (2017-2022)
Table 28. Global Intramuscular Vaccine Adjuvants Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Intramuscular Vaccine Adjuvants Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Intramuscular Vaccine Adjuvants Sales Market Share by Country/Region (2017-2022)
Table 32. Global Intramuscular Vaccine Adjuvants Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Intramuscular Vaccine Adjuvants Sales by Country (2017-2022) & (K Units)
Table 35. Americas Intramuscular Vaccine Adjuvants Sales Market Share by Country (2017-2022)
Table 36. Americas Intramuscular Vaccine Adjuvants Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2017-2022)
Table 38. Americas Intramuscular Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 39. Americas Intramuscular Vaccine Adjuvants Sales Market Share by Type (2017-2022)
Table 40. Americas Intramuscular Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 41. Americas Intramuscular Vaccine Adjuvants Sales Market Share by Application (2017-2022)
Table 42. APAC Intramuscular Vaccine Adjuvants Sales by Region (2017-2022) & (K Units)
Table 43. APAC Intramuscular Vaccine Adjuvants Sales Market Share by Region (2017-2022)
Table 44. APAC Intramuscular Vaccine Adjuvants Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Intramuscular Vaccine Adjuvants Revenue Market Share by Region (2017-2022)
Table 46. APAC Intramuscular Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 47. APAC Intramuscular Vaccine Adjuvants Sales Market Share by Type (2017-2022)
Table 48. APAC Intramuscular Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 49. APAC Intramuscular Vaccine Adjuvants Sales Market Share by Application (2017-2022)
Table 50. Europe Intramuscular Vaccine Adjuvants Sales by Country (2017-2022) & (K Units)
Table 51. Europe Intramuscular Vaccine Adjuvants Sales Market Share by Country (2017-2022)
Table 52. Europe Intramuscular Vaccine Adjuvants Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2017-2022)
Table 54. Europe Intramuscular Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 55. Europe Intramuscular Vaccine Adjuvants Sales Market Share by Type (2017-2022)
Table 56. Europe Intramuscular Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 57. Europe Intramuscular Vaccine Adjuvants Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Intramuscular Vaccine Adjuvants Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Intramuscular Vaccine Adjuvants
Table 67. Key Market Challenges & Risks of Intramuscular Vaccine Adjuvants
Table 68. Key Industry Trends of Intramuscular Vaccine Adjuvants
Table 69. Intramuscular Vaccine Adjuvants Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Intramuscular Vaccine Adjuvants Distributors List
Table 72. Intramuscular Vaccine Adjuvants Customer List
Table 73. Global Intramuscular Vaccine Adjuvants Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Intramuscular Vaccine Adjuvants Sales Market Forecast by Region
Table 75. Global Intramuscular Vaccine Adjuvants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Intramuscular Vaccine Adjuvants Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Intramuscular Vaccine Adjuvants Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Intramuscular Vaccine Adjuvants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Intramuscular Vaccine Adjuvants Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Intramuscular Vaccine Adjuvants Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Intramuscular Vaccine Adjuvants Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Intramuscular Vaccine Adjuvants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Intramuscular Vaccine Adjuvants Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Intramuscular Vaccine Adjuvants Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Intramuscular Vaccine Adjuvants Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Intramuscular Vaccine Adjuvants Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Intramuscular Vaccine Adjuvants Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Intramuscular Vaccine Adjuvants Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Intramuscular Vaccine Adjuvants Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Intramuscular Vaccine Adjuvants Revenue Market Share Forecast by Application (2023-2028)
Table 93. GSK Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Intramuscular Vaccine Adjuvants Product Offered
Table 95. GSK Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Dynavax Technologies Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 99. Dynavax Technologies Intramuscular Vaccine Adjuvants Product Offered
Table 100. Dynavax Technologies Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Dynavax Technologies Main Business
Table 102. Dynavax Technologies Latest Developments
Table 103. Novavax Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 104. Novavax Intramuscular Vaccine Adjuvants Product Offered
Table 105. Novavax Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Novavax Main Business
Table 107. Novavax Latest Developments
Table 108. Agenus Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 109. Agenus Intramuscular Vaccine Adjuvants Product Offered
Table 110. Agenus Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Agenus Main Business
Table 112. Agenus Latest Developments
Table 113. Croda International Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 114. Croda International Intramuscular Vaccine Adjuvants Product Offered
Table 115. Croda International Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Croda International Main Business
Table 117. Croda International Latest Developments
Table 118. Seppic Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 119. Seppic Intramuscular Vaccine Adjuvants Product Offered
Table 120. Seppic Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Seppic Main Business
Table 122. Seppic Latest Developments
Table 123. OZ Biosciences Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 124. OZ Biosciences Intramuscular Vaccine Adjuvants Product Offered
Table 125. OZ Biosciences Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. OZ Biosciences Main Business
Table 127. OZ Biosciences Latest Developments
Table 128. Phibro Animal Health Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 129. Phibro Animal Health Intramuscular Vaccine Adjuvants Product Offered
Table 130. Phibro Animal Health Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Phibro Animal Health Main Business
Table 132. Phibro Animal Health Latest Developments
Table 133. Associated British Foods Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 134. Associated British Foods Intramuscular Vaccine Adjuvants Product Offered
Table 135. Associated British Foods Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Associated British Foods Main Business
Table 137. Associated British Foods Latest Developments
Table 138. InvivoGen Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 139. InvivoGen Intramuscular Vaccine Adjuvants Product Offered
Table 140. InvivoGen Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. InvivoGen Main Business
Table 142. InvivoGen Latest Developments
Table 143. Merck KGaA Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 144. Merck KGaA Intramuscular Vaccine Adjuvants Product Offered
Table 145. Merck KGaA Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Merck KGaA Main Business
Table 147. Merck KGaA Latest Developments
Table 148. CSL Limited Basic Information, Intramuscular Vaccine Adjuvants Manufacturing Base, Sales Area and Its Competitors
Table 149. CSL Limited Intramuscular Vaccine Adjuvants Product Offered
Table 150. CSL Limited Intramuscular Vaccine Adjuvants Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. CSL Limited Main Business
Table 152. CSL Limited Latest Developments
List of Figures
Figure 1. Picture of Intramuscular Vaccine Adjuvants
Figure 2. Intramuscular Vaccine Adjuvants Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intramuscular Vaccine Adjuvants Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intramuscular Vaccine Adjuvants Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intramuscular Vaccine Adjuvants Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Infectious Diseases
Figure 10. Product Picture of Cancer
Figure 11. Product Picture of Others
Figure 12. Global Intramuscular Vaccine Adjuvants Sales Market Share by Type in 2021
Figure 13. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Type (2017-2022)
Figure 14. Intramuscular Vaccine Adjuvants Consumed in Research Applications
Figure 15. Global Intramuscular Vaccine Adjuvants Market: Research Applications (2017-2022) & (K Units)
Figure 16. Intramuscular Vaccine Adjuvants Consumed in Commercial Applications
Figure 17. Global Intramuscular Vaccine Adjuvants Market: Commercial Applications (2017-2022) & (K Units)
Figure 18. Global Intramuscular Vaccine Adjuvants Sales Market Share by Application (2017-2022)
Figure 19. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Application in 2021
Figure 20. Intramuscular Vaccine Adjuvants Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Company in 2021
Figure 22. Global Intramuscular Vaccine Adjuvants Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Geographic Region in 2021
Figure 24. Global Intramuscular Vaccine Adjuvants Sales Market Share by Region (2017-2022)
Figure 25. Global Intramuscular Vaccine Adjuvants Revenue Market Share by Country/Region in 2021
Figure 26. Americas Intramuscular Vaccine Adjuvants Sales 2017-2022 (K Units)
Figure 27. Americas Intramuscular Vaccine Adjuvants Revenue 2017-2022 ($ Millions)
Figure 28. APAC Intramuscular Vaccine Adjuvants Sales 2017-2022 (K Units)
Figure 29. APAC Intramuscular Vaccine Adjuvants Revenue 2017-2022 ($ Millions)
Figure 30. Europe Intramuscular Vaccine Adjuvants Sales 2017-2022 (K Units)
Figure 31. Europe Intramuscular Vaccine Adjuvants Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Intramuscular Vaccine Adjuvants Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue 2017-2022 ($ Millions)
Figure 34. Americas Intramuscular Vaccine Adjuvants Sales Market Share by Country in 2021
Figure 35. Americas Intramuscular Vaccine Adjuvants Revenue Market Share by Country in 2021
Figure 36. United States Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Intramuscular Vaccine Adjuvants Sales Market Share by Region in 2021
Figure 41. APAC Intramuscular Vaccine Adjuvants Revenue Market Share by Regions in 2021
Figure 42. China Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Intramuscular Vaccine Adjuvants Sales Market Share by Country in 2021
Figure 49. Europe Intramuscular Vaccine Adjuvants Revenue Market Share by Country in 2021
Figure 50. Germany Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Intramuscular Vaccine Adjuvants Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Intramuscular Vaccine Adjuvants Revenue Market Share by Country in 2021
Figure 57. Egypt Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Intramuscular Vaccine Adjuvants Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Intramuscular Vaccine Adjuvants in 2021
Figure 63. Manufacturing Process Analysis of Intramuscular Vaccine Adjuvants
Figure 64. Industry Chain Structure of Intramuscular Vaccine Adjuvants
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)